Document Detail

Prepregnancy low-plasma volume and predisposition to preeclampsia and fetal growth restriction.
MedLine Citation:
PMID:  21508747     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: : To estimate whether recurrence risks of preeclampsia, preterm birth, and fetal growth restriction relate to prepregnancy plasma volume.
METHODS: : We conducted a retrospective cohort study in 580 formerly preeclamptic women and a control group. In all women we measured plasma volume (iodine-human serum albumin indicator dilution method) in the nonpregnant state. One hundred seventy-eight normotensive (formerly preeclamptic) women had a subsequent pregnancy within the study period (1996-2008). Odds ratios (ORs) for recurrent preeclampsia, preterm birth, and small for gestational age (SGA) neonates were estimated, using multivariable logistic regression with adjustment for confounders.
RESULTS: : Plasma volumes were lower in women who developed recurrent preeclampsia (1,241±158 mL/m, 17% lower compared with women in the control group) than in women without recurrent preeclampsia (1,335±167 mL/m, 11% lower compared with women in the control group). Logistic regression analysis demonstrated that each 100-mL/m difference in plasma volume was associated with an OR of 0.6 (95% confidence interval [CI] 0.5-0.8) to develop recurrent preeclampsia in subsequent pregnancy. Risk of preterm delivery (before 37 weeks of gestation) depended on preeclampsia in subsequent pregnancy, the adjusted hazard ratio for preterm birth was 0.9 (95% CI 0.7-1.1) for each 100-mL/m change in plasma volume. Risk of delivering an SGA neonate was independent of recurrent preeclampsia. Each 100-mL/m change in plasma volume was associated with an adjusted OR of 0.8 (95% CI 0.5-0.9) to deliver an SGA neonate in subsequent pregnancy.
CONCLUSION: : The risk of recurrent preeclampsia and fetal growth restriction in subsequent pregnancy relates inversely and linearly to prepregnancy plasma volume.
Ralph R Scholten; Simone Sep; Louis Peeters; Maria T E Hopman; Fred K Lotgering; Marc E A Spaanderman
Related Documents :
16711617 - Assisted reproductive technology (art) in the upstate: reducing the risks of multiple b...
18509787 - Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis ...
24428147 - Adapting the pregnancy physical activity questionnaire for japanese pregnant women.
17414837 - Cholestasis and cholestatic syndromes.
107917 - The use of plasmapheresis in pregnancy with antenatal prediction of a serious hemolytic...
3229547 - Aortic valve replacement in the second trimester of pregnancy: a case report.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  117     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1085-93     Citation Subset:  AIM; IM    
From the Departments of Obstetrics and Gynecology and Physiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and the Departments of Obstetrics and Gynecology and Epidemiology, Medical University Centre Maastricht, Maastricht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Admixture mapping to identify spontaneous preterm birth susceptibility loci in African Americans.
Next Document:  Duration of menopausal hot flushes and associated risk factors.